What is known about eltrombopag passing into breast milk?

Whether eltrombopag or its metabolites enter human milk is unknown, animal studies suggest milk secretion, and risk to the breastfed child cannot be excluded, so stopping breast-feeding or continuing/abstaining from Revolade therapy must be decided by weighing breast-feeding benefits for the child against treatment benefits for the woman.